Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ocular BL1332 for Postoperative Ocular Pain Following PRK
NCT07412496Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BL1332 in postoperative pain, sponsored by Bausch + Lomb. Started Mar 2026; status: completed.
02
Drugs
BL1332
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07412496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07412496.